The Board of Directors at its meeting held today i.e. 12th May, 2025, has, inter alia: 1. Approved Audited Standalone and Consolidated Financial Results of the Company for the quarter ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved audited standalone and consolidated financial results for Q4 and the full year ended 31st March 2025. FY25 revenue from operations grew about 14% YoY to Rs 184.49 crore, with total income at Rs 190.53 crore. Full-year net profit was Rs 18.31 crore versus Rs 18.14 crore last year, while Q4 standalone net profit fell sharply from Rs 5.49 crore to Rs 1.60 crore. An exceptional item of Rs 2.61 crore was booked for diminution in the value of the company's investment in its wholly-owned Singapore subsidiary (Alufluoride International Pte Ltd), which reported a total comprehensive loss of Rs 2.83 crore for the year. The Board recommended a final dividend of Rs 3 per share (30% on face value); record date is 13th June 2025 and AGM is 23rd June 2025. Auditors issued an unmodified opinion on both standalone and consolidated results.
Solid revenue growth and a steady dividend are positives for shareholders, but the steep Q4 profit drop and write-down of the overseas subsidiary may temper sentiment on near-term earnings quality.